Roadblocks ahead on the WHO Roadmap on Access to Medicines and Vaccines?

By Katy Athersuch [1] and Thiru Balasubramaniam In May 2018, the World Health Assembly (WHA) adopted decision WHA71(8) requesting WHO’s Director-General to “elaborate a roadmap, in consultation with Member States, outlining the programming of WHO’s work on access to medicines… Continue Reading

Comments on NIH Prospective Exclusive License on Diabetes Treatments

Update. NIH sent us a 147 word response on November 23, 2018: NIH to KEI regarding Ovensa 23 NOV 2018. The brief reply states that “Prior to posting notices of a proposed grant of exclusive commercialization licenses, the NIH determines… Continue Reading

TRIPS Council (November 2018): Statement of South Africa on Promoting Public Health Through Competition Law and Policy

On 9 November 2018, South Africa delivered the following statement on IP and competition policy at the WTO TRIPS Council under agenda item 13 on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy (an… Continue Reading

WIPO General Assembly 2018: Statement of the United States on Copyright Exceptions and Limitations

On 26 September 2018, at the 2018 WIPO General Assembly, the United States of America delivered the following intervention on Copyright Exceptions and Limitations. World Intellectual Property Organization Assemblies of the Member States September 24 to October 2, 2018 AGENDA… Continue Reading

WIPO General Assembly 2018: Statement of the United States on the WIPO Treaty for the Protection of Broadcasting Organizations

On 26 September 2018, at the 2018 WIPO General Assembly, the United States of America made the following intervention on the WIPO Treaty for the Protection of Broadcasting Organizations. World Intellectual Property Organization Assemblies of the Member States September 24… Continue Reading